Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.375
Bid: 4.25
Ask: 4.50
Change: 0.00 (0.00%)
Spread: 0.25 (5.882%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 4.375
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS SUMMARY: IPF Rises As June Collections Improve

Fri, 10th Jul 2020 10:43

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.

----------

FTSE 100 - WINNERS

----------

Barclays, up 1.2%. Investec raised the lender to Buy from Hold.

----------

FTSE 250 - WINNERS

----------

Petropavlovsk, up 3.0%. The gold miner said Non-Executive Chair Peter Hambro, Chief Executive Alya Samokhvalova, Non-Executive Directors Johnny Smith, Martin Smith and Angelica Phillips will remain directors of the firm after the court requested a full hearing of Everest Alliance Ltd's application to remove them from their roles. Petropavlovsk said that while the judge found that Everest's complaints that the directors were not validly appointed were arguable, he declined to determine its application summarily and instead now requires a full hearing of Everest's application. Earlier on Friday, Everest - which has a 7.5% stake - requisitioned a general meeting to propose the hire of two new directors. The resolutions to be put forth at the meeting requested include the appointment of Paul Bushell and Ivan Kulakov as directors, the re-hire of James Cameron, Charlotte Phillipps, Katia Ray and Maxim Kharin in the event they have been removed as directors. Everest is looking to remove Hambro, Samokhvalova, Johnny Smith, Martin Smith and Phillips from the board. Everest also wants the removal of any other director that may have been appointed since Thursday until the end of the requisitioned meeting.

----------

FTSE 250 - LOSERS

----------

Senior, down 2.8%. The technology components manufacturer expressed a confident outlook going forward despite expecting to report a revenue fall in the first half of 2020. Senior reported a "robust" cash performance in the six months to the end of June, with GBP3 million net cash inflow generated during the period, in the face of "significant disruption" to its end markets. The company said it now expects revenue in the first half of 2020 to be around 30% lower than GBP580.4 million generated in the first half of 2019. Senior said net debt is expected to be GBP239 million at June 30, an improvement of GBP3 million from the end of December 2019. In 2019, in order to counter the anticipated decline in sales, Senior initiated a restructuring plan. Reflecting the additional actions which the company is taking, it now expects the total restructuring charge to be up to GBP35 million, an increase from the GBP23 million originally anticipated. Going forward, Senior said trading for the rest of 2020 continues to be hurt by Covid-19. As a result, guidance for 2020 remains suspended.

----------

OTHER MAIN MARKET AND AIM - WINNERS

----------

Marston's, up 2.5%. JPMorgan resumed the brewer with Neutral.

----------

International Personal Finance, up 15%. The home credit business said it is "well-placed" going forward as its collections effectiveness continued to improve in June. The company said it is encouraged by the extent to which the company is now stabilising into a "new normal" operational environment. International Personal Finance said collections effectiveness continued to improve in June, reaching 88% of pre-Covid expectations. It was at 76% in April and 80% in May. Going forward, the company said it expects collections effectiveness to progressively improve in the coming months. International Personal Finance said there is a continuing strong demand for its products. As lockdown restrictions are progressively relaxed and the company's collections effectiveness is improved, it said it has increased credit issued. In June, the company lent 37% of pre-Covid expectations, up from 30% during both of April and May.

----------

SRT Marine Systems, up 19%. The maritime surveillance provider announced the resumption of its Philippines fisheries management system project, with a significant cash payment being received in the week. The revised Philippines project plan agreed with SRT's customer is looking to accelerate implementation to make up for as much time lost as possible due to the five month pause. Meanwhile, in the Middle East final contract negotiations have recommenced and subject to completion of internal processes, these are expected to conclude soon with the projects starting in the coming months. Finally, SRT's Transcievers business has performed better than expected despite the current circumstances, achieving gross sales in the first quarter ended June 30 up 2% from the same period the year before.

----------

Focusrite, up 6.1%. The AIM-listed music & audio products company said revenue and profit are currently ahead of the company's expectations for the year to the end of August. Focusrite noted that the demand for its Audio Engineering and ADAM Audio products has been strong during the widespread lockdowns that have occurred as a result of Covid-19, thanks to widespread availability globally through e-commerce platforms. In addition, consumer registrations of products primarily focused on home recording equipment have risen. Conversely, demand for Martin Audio products has been significantly lower than pre-Covid levels of expectation due to the suspension of live music tours and festivals, although demand is now starting to show modest signs of recovery driven by the installed sound segment. Similarly, Focusrite Pro has seen muted performance as well, although the pipeline across education, post-production and installed sound is now showing signs of recovery.

----------

OTHER MAIN MARKET AND AIM - LOSERS

----------

Genedrive, down 13%. The molecular diagnostics firm expects its full year revenue to be sharply lower but in line with internal guidance. For the year to June 30, Genedrive expects its revenue to come in at GBP1.0 million from GBP2.4 million the year before. Looking ahead, Genedrive said it has received "significant" interest in its 96 SARS-CoV-2 kit, but obtaining regulatory approval is "taking longer than anticipated" and the regulatory agencies the firm is dealing with is "unable to provide definitive timelines for approvals".

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
19 May 2023 16:03

Genedrive jumps on draft NICE testing guidance

(Sharecast News) - Point-of-care molecular diagnostics company Genedrive announced on Friday that the UK's National Institute for Health and Care Excellence (NICE) has issued draft guidance recommending the use of CYP2C19 genotyping before administering clopidogrel in the management of ischemic stroke (IS) patients.

Read more
19 May 2023 10:24

Genedrive says NICE committee recommends CYP2C19 for stroke patients

(Alliance News) - Genedrive PLC on Friday said draft guidance from the UK's National Institute for Health & Care Excellence has recommended that CYP2C19 genotyping should be used to manage ischemic stroke patients.

Read more
19 May 2023 10:15

AIM WINNERS & LOSERS: iEnergizer to depart; Unbound for sale

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
4 May 2023 16:11

UK shareholder meetings calendar - next 7 days

Friday 5 May 
abrdn Smaller Companies Income Trust PLCAGM
Holders Technology PLCAGM
HSBC Holdings PLCAGM
InterContinental Hotels Group PLCAGM
James Fisher & Sons PLCAGM
Man Group PLCAGM
Rightmove PLCAGM
UK Oil & Gas PLCAGM
Monday 8 May 
no events scheduled 
Tuesday 9 May 
Caledonia Mining Corp PLCAGM
Direct Line Insurance Group PLCAGM
Foxtons Group PLCAGM
Hostelworld Group PLCAGM
IWG PLCAGM
Just Group PLCAGM
Midwich Group PLCAGM
Osirium Technologies PLCAGM
Windward LtdAGM
Wednesday 10 May 
abrdn PLCAGM
Antofagasta PLCAGM
Cenkos Securities PLCAGM
Ecora Resources PLCAGM
H&T Group PLCAGM
Harbour Energy PLCAGM
Jupiter Fund Management PLCAGM
Literacy Capital PLCAGM
Luceco PLCAGM
Marshalls PLCAGM
National Express Group PLCAGM
Renewables Infrastructure Group LtdAGM
Rentokil Initial PLCAGM
Seplat Energy PLCAGM
Spirax-Sarco Engineering PLCAGM
TClarke PLCAGM
Thursday 11 May 
88 Energy LtdAGM
Cairn Homes PLCAGM
Capita PLCAGM
Clarkson PLCAGM
Costain Group PLCAGM
Eleco PLCAGM
Eurocell PLCAGM
FBD Holdings PLCAGM
Genedrive PLCGM re Equity Prepayment Facility
Genel Energy PLCAGM
Gresham House PLCAGM
Gym Group PLCAGM
Hiscox LtdAGM
Irish Continental Group PLCAGM
John Wood Group PLCAGM
MyHealthChecked PLCAGM
OSB Group PLCAGM
Poolbeg Pharma PLCAGM
Rolls-Royce Holdings PLCAGM
Serinus Energy PLCAGM
Uniphar PLCAGM
Videndum PLCAGM
WAG Payment Solutions PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
31 Mar 2023 20:33

IN BRIEF: Genedrive sees acceleration of revenue in 2023

Genedrive PLC - Manchester, England-based point-of-care molecular diagnostics company - Reports revenue in the six months to December 31 of GBP20,000 compared to nothing a year prior, and an operating loss of GBP2.7 million from GBP2.8 million. Confident that the company will see an acceleration of revenues through 2023 and going forwards. Agrees GBP5 million equity prepayment facility with Riverfort Global Opportunities PCC Ltd with an initial drawn amount of GBP2 million, expected to be received in early April. Proceeds will be used towards the commercialisation of the antibiotic induced hearing loss test, Genedrive MT-RNR1 ID Kit and enhancing the Genedrive platform as well as providing additional working capital. Directors believe the facility is the best option available at present.

Read more
30 Mar 2023 11:18

Genedrive MT-RNR1 ID kit receives final UK NICE recommendation for NHS

(Alliance News) - Genedrive PLC on Thursday said the UK National Institute for Health & Care Excellence ratified and finalised its recommendation that Genedrive's hearing loss gene screening test MT-RNR1 ID kit can be used by the NHS.

Read more
30 Mar 2023 07:57

LONDON BRIEFING: Stocks add to rebound; SSE ups earnings guidance

(Alliance News) - Stocks in London are set to build on Wednesday's gains, as risk appetite recovers following the recent banking turmoil.

Read more
20 Mar 2023 09:37

AIM WINNERS & LOSERS: Tribal shares drop on NTU contract termination

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
20 Mar 2023 09:21

Genedrive to roll out hearing loss screening in two NHS sites

(Alliance News) - Genedrive PLC on Monday reported further progress in the rollout of its hearing loss gene screening test in the UK.

Read more
20 Mar 2023 08:53

LONDON MARKET OPEN: UBS down 15%, Credit Suisse down 60% after deal

(Alliance News) - Stock prices in London opened lower on Monday morning as the emergency takeover of beleaguered lender Credit Suisse over the weekend failed to quell market turmoil.

Read more
9 Feb 2023 12:05

LONDON MARKET MIDDAY: Standard Chartered takeover talks lift FTSE 100

(Alliance News) - Stock prices in London were largely higher at midday on Thursday, thanks to a strong set of results from drug maker AstraZeneca and renewed takeover talks for lender Standard Chartered.

Read more
9 Feb 2023 11:19

AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
9 Feb 2023 10:36

Genedrive hearing loss test recommended by UK health department body

(Alliance News) - Genedrive PLC on Thursday said the UK National Institute for Health & Care Excellence has preliminarily recommended its antibiotic hearing loss test, the MT-RNR1 ID kit.

Read more
9 Feb 2023 09:13

LONDON MARKET OPEN: BAT falls on sales miss; Entain hit by MGM remark

(Alliance News) - Stock prices in London opened higher on Thursday, as investors digested a mixed set of UK company earnings.

Read more
3 Feb 2023 10:26

AIM WINNERS & LOSERS: 88 Energy surges; Petro Matad plans fundraise

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.